Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases
- PMID: 22081483
- DOI: 10.1002/path.3959
Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases
Erratum in
- J Pathol. 2012 Aug;227(4):e8
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related death, largely due to metastatic disease. To better understand PDAC metastatic spread and identify novel therapeutic targets, we analysed the proteome of primary tumours and matched lymph node (LN) metastases. As frozen specimens of metastatic lesions are scarce, we examined formalin-fixed paraffin-embedded (FFPE) tissues. This poses technical challenges because of the cross-linkages induced by fixation. Using laser capture microdissection (PALM system), we isolated malignant epithelia from seven FFPE primary PDAC tumours and matched LN metastases. Following dissection, samples were analysed in duplicate using Multidimensional Protein Identification Technology (MudPIT); this resulted in the identification of 1504 proteins, 854 of which were common to all samples analysed. Comparison of the obtained proteins with data from previous proteomics studies on pancreatic tissue, pancreatic juice, serum, and urine resulted in a less than 30% overlap, indicating that our study has substantially expanded the current database of proteins expressed in this malignancy. Statistical analysis further showed that 115/854 proteins (13.5%) were significantly differentially expressed (g-value ≥ 3.8). Two proteins, S100P and 14-3-3 sigma, with highly significant g-values were confirmed to be significantly differentially expressed (S100P: p = 0.05 and 14-3-3 sigma: p < 0.001) in a larger series of 55 cases of matched primary PDAC and LN metastases using immunohistochemistry. Thus, laser capture microdissection of FFPE tissue coupled with downstream proteomic analysis is a valid approach for the investigation of metastatic PDAC. This is the first study to establish and compare the protein composition of primary PDAC and matched LN metastases, and has resulted in the identification of several potential epithelial-specific therapeutic targets, including 14-3-3 sigma and S100P.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.Int J Cancer. 2013 Mar 15;132(6):1368-82. doi: 10.1002/ijc.27797. Epub 2012 Sep 14. Int J Cancer. 2013. PMID: 22915188
-
Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.Pancreas. 2015 Jan;44(1):106-15. doi: 10.1097/MPA.0000000000000220. Pancreas. 2015. PMID: 25251443
-
Comparison of different tissue sampling methods for protein extraction from formalin-fixed and paraffin-embedded tissue specimens.Exp Mol Pathol. 2010 Feb;88(1):190-6. doi: 10.1016/j.yexmp.2009.09.009. Epub 2009 Sep 24. Exp Mol Pathol. 2010. PMID: 19782068
-
Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.Curr Drug Targets. 2012 Nov;13(12):1475-87. doi: 10.2174/138945012803530125. Curr Drug Targets. 2012. PMID: 22974391 Review.
-
Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.Int J Mol Sci. 2021 Mar 6;22(5):2655. doi: 10.3390/ijms22052655. Int J Mol Sci. 2021. PMID: 33800786 Free PMC article.
Cited by
-
Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues.Proteomics. 2012 Apr;12(7):1045-58. doi: 10.1002/pmic.201100550. Proteomics. 2012. PMID: 22318899 Free PMC article. Review.
-
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.Cancers (Basel). 2022 May 13;14(10):2414. doi: 10.3390/cancers14102414. Cancers (Basel). 2022. PMID: 35626021 Free PMC article.
-
The life and works of S100P - from conception to cancer.Am J Cancer Res. 2016 Jan 15;6(2):562-76. eCollection 2016. Am J Cancer Res. 2016. PMID: 27186425 Free PMC article. Review.
-
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives.Front Oncol. 2021 Aug 30;11:711180. doi: 10.3389/fonc.2021.711180. eCollection 2021. Front Oncol. 2021. PMID: 34527585 Free PMC article. Review.
-
Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges.Proteomics. 2013 Feb;13(3-4):710-21. doi: 10.1002/pmic.201200319. Epub 2013 Jan 7. Proteomics. 2013. PMID: 23125171 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous